Vimian Group AB (VIMIAN)

Stockholm
Currency in SEK
40.15
+0.45(+1.13%)
Closed
VIMIAN Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
39.1540.55
52 wk Range
25.1847.20
Key Statistics
Edit
Prev. Close
40.15
Open
39.7
Day's Range
39.15-40.55
52 wk Range
25.18-47.2
Volume
260.18K
Average Volume (3m)
531.63K
1-Year Change
42.49%
Book Value / Share
14.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VIMIAN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
47.15
Upside
+17.43%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period
Show more

Vimian Group AB Company Profile

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.

Employees
1100
Market
Sweden

Compare VIMIAN to Peers and Sector

Metrics to compare
VIMIAN
Peers
Sector
Relationship
P/E Ratio
7,220.7x−1.3x−0.6x
PEG Ratio
71.30−0.010.00
Price/Book
2.8x2.5x2.6x
Price / LTM Sales
5.2x2.9x3.1x
Upside (Analyst Target)
24.1%45.5%48.8%
Fair Value Upside
Unlock7.7%7.5%Unlock

Analyst Ratings

5 Buy
1 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 47.15
(+17.43% Upside)

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Vimian Group AB (VIMIAN) Stock Price Today?

The Vimian Group AB stock price today is 40.15.

What Stock Exchange Does Vimian Group AB Trade On?

Vimian Group AB is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Vimian Group AB?

The stock symbol for Vimian Group AB is "VIMIAN."

What Is the Vimian Group AB Market Cap?

As of today, Vimian Group AB market cap is 21.01B.

What is Vimian Group AB Earnings Per Share?

The Vimian Group AB EPS is 0.001.

From a Technical Analysis Perspective, Is VIMIAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.